Catheter Precision (VTAK) Shares Outstanding (2017 - 2026)

Catheter Precision (VTAK) has 10 years of Shares Outstanding data on file, last reported at $2.7 million in Q1 2026.

• Shares Outstanding for Q1 2026 came in at $2.7 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 million (changed N/A YoY), and the FY2025 annual result was $2229.0, down 99.47% from the prior year.
• Shares Outstanding rose to $2.7 million in Q1 2026 per VTAK's latest filing, from $2229.0 in the prior quarter.
• Over five years, Shares Outstanding peaked at $2.7 million in Q1 2026 and troughed at $3703.0 in Q2 2024.
• A 5-year average of $763950.2 and a median of $590883.5 in 2022 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding jumped 993789.23% in 2022, then tumbled 100.0% in 2023.
• A 5-year view of Shares Outstanding shows it stood at $646.0 million in 2022, then tumbled by 100.0% to $4578.0 in 2023, then jumped by 9102.62% to $421296.0 in 2024, then plunged by 99.47% to $2229.0 in 2025, then jumped by 120692.87% to $2.7 million in 2026.
• Business Quant data shows VTAK's Shares Outstanding at $2.7 million in Q1 2026, $2229.0 in Q4 2025, and $1.6 million in Q3 2025.